H/2813 - Purchase, Importation, Storage, QP certification, Distribution and Labelling of Drug for Clinical Trial
University of Leedsservices
What the buyer wrote
The Clinical Trial Research Unit at the University of Leeds is seeking tenders for the Purchase, importation, distribution, storage, labelling and QP release of a drug for a clinical trial. The Clinical Trial is called ReoGlio and it is looking at a new treatment combination in adult patients with glioblastoma multiforme. The two medicinal products to be used in combination are the reovirus (REOLYSIN®) and GM-CSF which will be given alongside the standard of care chemoradiotherapy (6 weeks) and adjuvant chemotherapy (6 months). The study will look at the safety and tolerability of this combination. We will recruit up to 24 participants and we hope to open to recruitment by Ma…
Details
- What the buyer calls it
- H/2813 - Purchase, Importation, Storage, QP certification, Distribution and Labelling of Drug for Clinical Trial
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- services
- Work starts
- 30 Apr 2017
- Work ends
- 1 Nov 2018
Who the buyer named
Ellie Cope was the named contact on this notice.